By Moody's — Teva Pharmaceutical Industries Ltd. Receives Moody’s Upgrade to Investment-Grade Baa3 Rating Quiver Quantitative
Read the original at Moody's ↗
Auto-published by the finit.news Events monitor from Moody's; summarized by AI and may contain errors — verify against the primary source. August 11, 2026.